1)Cole PJ. Inflammation : a two-edged sword--the model of bronchiectasis. Eur J Respir Dis Suppl 1986 ; 147 : 6-15.
2)Aliberti S, Goeminne PC, O'Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials : international consensus recommendations. Lancet Respir Med 2022 ; 10 : 298-306.
3)Zhou YM, Wang C, Yao WZ, et al. [The prevalence and risk factors of bronchiectasis in residents aged 40 years old and above in seven cities in China]. Zhonghua Nei Ke Za Zhi 2013 ; 52 : 379-82.
4)Quint JK, Millett ER, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013 : a population-based cohort study. Eur Respir J 2016 ; 47 : 186-93.
5)Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis 2017 ; 14 : 377-84.
6)Gao YH, Guan WJ, Liu SX, et al. Aetiology of bronchiectasis in adults : A systematic literature review. Respirology 2016 ; 21 : 1376-83.
7)Chalmers JD, Polverino E, Crichton ML, et al. Bronchiectasis in Europe : data on disease characteristics from the European Bronchiectasis registry(EMBARC). Lancet Respir Med 2023 ; 11 : 637-49.
8)Kadowaki T, Yano S, Wakabayashi K, et al. An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis. Respir Investig 2015 ; 53 : 37-44.
9)Asakura T, Morimoto K, Ito A, et al. Etiology and Health-Related Quality of Life in Non-Cystic Fibrosis Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease : The First Analysis of the Japanese Nontuberculous Mycobacteriosis-Bronchiectasis Registry. B106 BREAKTHROUGHS IN NTM DIAGNOSIS AND TREATMENT. American Thoracic Society 2020 ; A4370-A70.
10)Morimoto K, Iwai K, Yoshiyama T, et al. Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis : comparative study using national mortality statistics from 1970 to 2015 in Japan. ERJ Open Res 2023 ; 9 : 00424-2022.
11)Fujita K, Ito Y, Hirai T, et al. Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease. BMJ Open Respir Res 2014 ; 1 : e000050.
12)Urabe N, Sakamoto S, Shimanuki Y, et al. Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation. BMC Pulm Med 2022 ; 22 : 157.
13)Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India : results from the European Multicentre Bronchiectasis Audit and Research Collaboration(EMBARC)and Respiratory Research Network of India Registry. Lancet Glob Health 2019 ; 7 : e1269-79.
14)大石修司,人見秀昭,酒井正雄,他.Swyer-James症候群5例の臨床的検討.日胸疾患会誌1995 ; 33 : 1401-7.
15)Park MA, Li JT, Hagan JB, et al. Common variable immunodeficiency : a new look at an old disease. Lancet 2008 ; 372 : 489-502.
16)Hill AT, Sullivan AL, Chalmers JD, et al. British Thoracic Society guideline for bronchiectasis in adults. BMJ Open Respir Res 2018 ; 5 : e000348.
17)Du Q, Jin J, Liu X, et al. Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease : A Systematic Review and Meta-Analysis. PLoS One 2016 ; 11 : e0150532.
18)Metersky ML, Dransfield MT. The Chronic Obstructive Pulmonary Disease(COPD)-Bronchiectasis Overlap Syndrome : Does My COPD Patient Have Bronchiectasis on Computed Tomography? “Frankly, My Dear, I Don't Give a Damn!”. Am J Respir Crit Care Med 2023 ; 208 : 1265-7.
19)De Soyza A, McDonnell MJ, Goeminne PC, et al. Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis : A Multicenter Cohort Study. Chest 2017 ; 151 : 1247-54.
20)Lin HC, Huang HY, Lin CY, et al. Clinical outcomes and prognostic factors of bronchiectasis rheumatoid overlap syndrome : A multi-institution cohort study. Front Med(Lausanne)2022 ; 9 : 1004550.
21)Pulmonology Portuguese Society Bronchiectasis Study Group. Recommendations for aetiological diagnosis of bronchiectasis. Rev Port Pneumol(2006)2016 ; 22 : 222-35.
22)Maldonado F, Tazelaar HD, Wang CW, et al. Yellow nail syndrome : analysis of 41 consecutive patients. Chest 2008 ; 134 : 375-81.
23)Krustins E. Mounier-Kuhn syndrome : a systematic analysis of 128 cases published within last 25 years. Clin Respir J 2016 ; 10 : 3-10.
24)Dunne MG, Reiner B. CT features of tracheobronchomegaly. J Comput Assist Tomogr 1988 ; 12 : 388-91.
25)Woodring JH, Howard RS 2nd, Rehm SR. Congenital tracheobronchomegaly(Mounier-Kuhn syndrome) : a report of 10 cases and review of the literature. J Thorac Imaging 1991 ; 6 : 1-10.
26)Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007 ; 131 : 524-32.
27)Kuzela L, Vavrecka A, Prikazska M, et al. Pulmonary complications in patients with inflammatory bowel disease. Hepatogastroenterology 1999 ; 46 : 1714-9.
28)Mikami Y, Grubb BR, Rogers TD, et al. Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration. Sci Transl Med 2023 ; 15 : eabo7728.
29)Araújo D, Shteinberg M, Aliberti S, et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J 2017 ; 50 : 1701289.
30)Cooke JC, Currie DC, Morgan AD, et al. Role of computed tomography in diagnosis of bronchiectasis. Thorax 1987 ; 42 : 272-7.
31)Finch S, McDonnell MJ, Abo-Leyah H, et al. A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis. Ann Am Thorac Soc 2015 ; 12 : 1602-11.
32)Aksamit TR, O'Donnell AE, Barker A, et al. Adult Patients With Bronchiectasis : A First Look at the US Bronchiectasis Research Registry. Chest 2017 ; 151 : 982-92.
33)Pifferi M, Bush A, Caramella D, et al. Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia. Eur Respir J 2011 ; 37 : 566-71.
34)Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017 ; 50 : 1700629.